157 related articles for article (PubMed ID: 8851613)
21. Biliary tract excretion of ofloxacin in man.
Kazmierczak A; Pechinot A; Duez JM; Haas O; Favre JP
Drugs; 1987; 34 Suppl 1():39-43. PubMed ID: 3481327
[TBL] [Abstract][Full Text] [Related]
22. In-vitro activity of fleroxacin against isolates causing complicated urinary tract infections and concentrations in seminal and prostatic fluid and in prostatic adenoma tissue.
Naber KG; Sörgel F; Kees F; Schumacher H; Metz R; Grobecker H
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():199-207. PubMed ID: 2462556
[TBL] [Abstract][Full Text] [Related]
23. Penetration of fleroxacin into prostatic secretion and prostatic adenoma tissue.
Kees F; Naber KG; Schumacher H; Grobecker H
Chemotherapy; 1988; 34(6):437-43. PubMed ID: 2468456
[TBL] [Abstract][Full Text] [Related]
24. Penetration of fleroxacin into maxillary sinus mucosa and palatine tonsil.
Baba S; Mori Y; Maruo T
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():195-7. PubMed ID: 3144538
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of [18F]fleroxacin in healthy human subjects studied by using positron emission tomography.
Fischman AJ; Livni E; Babich J; Alpert NM; Liu YY; Thom E; Cleeland R; Prosser BL; Correia JA; Strauss HW
Antimicrob Agents Chemother; 1993 Oct; 37(10):2144-52. PubMed ID: 8257137
[TBL] [Abstract][Full Text] [Related]
26. The penetration of fleroxacin into bronchial mucosa.
Wise R; Honeybourne D; Andrews JM; Ashby JP
J Antimicrob Chemother; 1988 Aug; 22(2):203-6. PubMed ID: 3141344
[TBL] [Abstract][Full Text] [Related]
27. High-performance liquid chromatographic assay and erythrocyte partitioning of fleroxacin, a new fluoroquinolone antibiotic.
Brunt E; Limberg J; Derendorf H
J Pharm Biomed Anal; 1990; 8(1):67-71. PubMed ID: 2129330
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of fleroxacin after multiple oral dosing in patients receiving regular hemodialysis.
Uehlinger DE; Schaedeli F; Kinzig M; Sörgel F; Frey FJ
Antimicrob Agents Chemother; 1996 Aug; 40(8):1903-9. PubMed ID: 8843301
[TBL] [Abstract][Full Text] [Related]
29. Complicated urinary infection in spinal injury patients: fleroxacin compared with ciprofloxacin.
Whitby M; Angus L; Nimmo G; Hill V
Chemotherapy; 1996; 42(6):468-72. PubMed ID: 8957583
[TBL] [Abstract][Full Text] [Related]
30. Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans.
Weidekamm E; Portmann R; Suter K; Partos C; Dell D; Lücker PW
Antimicrob Agents Chemother; 1987 Dec; 31(12):1909-14. PubMed ID: 3125788
[TBL] [Abstract][Full Text] [Related]
31. The penetration of fleroxacin into intra-abdominal abscesses.
Youngs DJ; Tudor RG; Yoshioka K; Keighley MR
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():115-8. PubMed ID: 3144528
[TBL] [Abstract][Full Text] [Related]
32. The metabolism and pharmacokinetics of fleroxacin in healthy subjects.
Griggs DJ; Wise R; Kirkpatrick B; Ashby JP
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():191-4. PubMed ID: 3144537
[TBL] [Abstract][Full Text] [Related]
33. Clinical pharmacokinetics and tolerance of fleroxacin in healthy male volunteers.
Nakashima M; Kanamaru M; Uematsu T; Takiguchi A; Mizuno A; Itaya T; Kawahara F; Ooie T; Saito S; Uchida H
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():133-44. PubMed ID: 3144532
[TBL] [Abstract][Full Text] [Related]
34. Fleroxacin overview.
Naber KG
Chemotherapy; 1996 Mar; 42 Suppl 1():1-9. PubMed ID: 8861529
[TBL] [Abstract][Full Text] [Related]
35. [Ciprofloxacine: evaluation of its biliary elimination in man].
Brogard JM; Jehl F; Arnaud JP; Lévy P; Peladan F; Blicklé JF; Monteil H
Schweiz Med Wochenschr; 1985 Mar; 115(13):448-53. PubMed ID: 3158073
[TBL] [Abstract][Full Text] [Related]
36. Fleroxacin pharmacokinetics in healthy volunteers and impaired renal function.
Höffler D; Koeppe P; Metz R; Pech M; Sörgel F
J Chemother; 1989 Jul; 1(4 Suppl):558-60. PubMed ID: 16312531
[No Abstract] [Full Text] [Related]
37. Pharmacokinetics of fleroxacin determined by biological method.
Verbist L; Van Hecken A; De Schepper P
J Chemother; 1989 Jul; 1(4 Suppl):572-3. PubMed ID: 16312537
[No Abstract] [Full Text] [Related]
38. Pharmacokinetics of fleroxacin in horses.
Rebuelto M; Otero P; Albarellos G; Ambros L; Kreil V; Waxman S; Montoya L; Hallu R
J Vet Pharmacol Ther; 2000 Apr; 23(2):103-5. PubMed ID: 10849255
[No Abstract] [Full Text] [Related]
39. Pharmacokinetics and tissue penetration of fleroxacin after single and multiple 400- and 800-mg-dosage regimens.
Panneton AC; Bergeron MG; LeBel M
Antimicrob Agents Chemother; 1988 Oct; 32(10):1515-20. PubMed ID: 3142338
[TBL] [Abstract][Full Text] [Related]
40. Fleroxacin concentrations in myometrium, ovary and fallopian tube.
Portmann R; Hansz C; Stiglmayer R; Weidekamm E
J Antimicrob Chemother; 1989 Apr; 23(4):662-4. PubMed ID: 2501273
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
